Literature DB >> 27782335

The "ins and outs" of complement-driven immune responses.

Simon Freeley1, Claudia Kemper2,3, Gaëlle Le Friec1.   

Abstract

The complement system represents an evolutionary old and critical component of innate immunity where it forms the first line of defense against invading pathogens. Originally described as a heat-labile fraction of the serum responsible for the opsonization and subsequent lytic killing of bacteria, work over the last century firmly established complement as a key mediator of the general inflammatory response but also as an acknowledged vital bridge between innate and adaptive immunity. However, recent studies particularly spanning the last decade have provided new insights into the novel modes and locations of complement activation and highlighted unexpected additional biological functions for this ancient system, for example, in regulating basic processes of the cell. In this review, we will cover the current knowledge about complement's established and novel roles in innate and adaptive immunity with a focus on the functional differences between serum circulating and intracellularly active complement and will describe and discuss the newly discovered cross-talks of complement with other cell effector systems particularly during T-cell induction and contraction.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; adaptive immunity; cell metabolism; complement; complosome; inflammasomes

Mesh:

Substances:

Year:  2016        PMID: 27782335      PMCID: PMC5102160          DOI: 10.1111/imr.12472

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  168 in total

Review 1.  The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.

Authors:  V M Holers; T Kinoshita; H Molina
Journal:  Immunol Today       Date:  1992-06

2.  The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response.

Authors:  Alberto Baroja-Mazo; Fatima Martín-Sánchez; Ana I Gomez; Carlos M Martínez; Joaquín Amores-Iniesta; Vincent Compan; Maria Barberà-Cremades; Jordi Yagüe; Estibaliz Ruiz-Ortiz; Jordi Antón; Segundo Buján; Isabelle Couillin; David Brough; Juan I Arostegui; Pablo Pelegrín
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

Review 3.  NLRP3 inflammasomes link inflammation and metabolic disease.

Authors:  Dominic De Nardo; Eicke Latz
Journal:  Trends Immunol       Date:  2011-07-04       Impact factor: 16.687

4.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

5.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

6.  Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire.

Authors:  Sherry D Fleming; Terez Shea-Donohue; Joel M Guthridge; Liudmila Kulik; Thomas J Waldschmidt; Matthew G Gipson; George C Tsokos; V Michael Holers
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

7.  Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.

Authors:  R T White; D Damm; N Hancock; B S Rosen; B B Lowell; P Usher; J S Flier; B M Spiegelman
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

8.  Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst.

Authors:  M U Ehrengruber; T Geiser; D A Deranleau
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

9.  IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival.

Authors:  Jessica A Wofford; Heather L Wieman; Sarah R Jacobs; Yuxing Zhao; Jeffrey C Rathmell
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

10.  Structure of the poly-C9 component of the complement membrane attack complex.

Authors:  Natalya V Dudkina; Bradley A Spicer; Cyril F Reboul; Paul J Conroy; Natalya Lukoyanova; Hans Elmlund; Ruby H P Law; Susan M Ekkel; Stephanie C Kondos; Robert J A Goode; Georg Ramm; James C Whisstock; Helen R Saibil; Michelle A Dunstone
Journal:  Nat Commun       Date:  2016-02-04       Impact factor: 14.919

View more
  42 in total

Review 1.  Complement's hidden arsenal: New insights and novel functions inside the cell.

Authors:  M Kathryn Liszewski; Michelle Elvington; Hrishikesh S Kulkarni; John P Atkinson
Journal:  Mol Immunol       Date:  2017-02-10       Impact factor: 4.407

Review 2.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

Review 3.  Novel mechanisms and functions of complement.

Authors:  George Hajishengallis; Edimara S Reis; Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Immunol       Date:  2017-11-16       Impact factor: 25.606

4.  Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy.

Authors:  Jeremy D Rubinstein; Xiang Zhu; Carolyn Lutzko; Tom Leemhuis; Jose A Cancelas; Sonata Jodele; Catherine M Bollard; Patrick J Hanley; Stella M Davies; Michael S Grimley; Adam S Nelson
Journal:  Blood Adv       Date:  2020-07-28

5.  Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade.

Authors:  Haoran Zha; Xiao Han; Ying Zhu; Fei Yang; Yongsheng Li; Qijing Li; Bo Guo; Bo Zhu
Journal:  Oncoimmunology       Date:  2017-07-13       Impact factor: 8.110

Review 6.  Complement in cancer: untangling an intricate relationship.

Authors:  Edimara S Reis; Dimitrios C Mastellos; Daniel Ricklin; Alberto Mantovani; John D Lambris
Journal:  Nat Rev Immunol       Date:  2017-09-18       Impact factor: 53.106

Review 7.  Neutrophils and Bacterial Immune Evasion.

Authors:  Scott D Kobayashi; Natalia Malachowa; Frank R DeLeo
Journal:  J Innate Immun       Date:  2018-04-11       Impact factor: 7.349

8.  Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Authors:  Jeffrey L Platt; Marilia Cascalho; Jorge A Piedrahita
Journal:  ILAR J       Date:  2018-12-31

9.  Endothelial cell-specific overexpression of developmental endothelial locus-1 does not influence atherosclerosis development in ApoE-/- mice.

Authors:  Pallavi Subramanian; Marta Prucnal; Bettina Gercken; Matina Economopoulou; George Hajishengallis; Triantafyllos Chavakis
Journal:  Thromb Haemost       Date:  2017-08-10       Impact factor: 5.249

Review 10.  The renaissance of complement therapeutics.

Authors:  Daniel Ricklin; Dimitrios C Mastellos; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.